Shock Wave Lithotripsy Using Fluoroscopic Versus Ultrasonic Localization

July 6, 2023 updated by: Egymedicalpedia

Shock Wave Lithotripsy Using Fluoroscopic Versus Ultrasonic Localization for Pediatric Renal Stones.

Epidemiological studies have shown a progressive increase in the incidence of pediatric urolithiasis over the past few decades.

Study Overview

Detailed Description

Pediatric stone disease is considered endemic in developing nations including Turkey, Pakistan, and eastern countries. The introduction of SWL by Chaussy et al. in the early 1980s revolutionized the management of upper urinary tract calculus disease.

Reports of successful SWL in children were first published in 1986; then several reports showed safety, and stone-free rates comparable with those of adults. For successful SWL, accurate localization of the shock waves is performed by ultrasound (US) or fluoroscope (FS) to fully focus the shock waves on the stone

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Qinā, Egypt
        • Urology department - faculty of medicine, South Valley university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 16 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Children (2-16) years of age with radiopaque renal pelvic stones less than 20 mm

Exclusion Criteria:

  1. Previous percutaneous nephrolithotripsy at the same side.
  2. Previous renal exploration for stones at the same side.
  3. Positive urinary culture.
  4. Calyceal stones

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: fluoroscopic focus Shock wave lithotripsy
Shock wave lithotripsy, accurate localization of the shock waves is performed by the fluoroscope (FS) to fully focus the shock waves on the stone
successful Shock wave lithotripsy , accurate localization of the shock waves is performed by ultrasound (US) to fully focus the shock waves on the stone
successful Shock wave lithotripsy , accurate localization of the shock waves is performed by fluoroscope (FS) to fully focus the shock waves on the stone
Active Comparator: ultrasonic focus Shock wave lithotripsy
Shock wave lithotripsy, accurate localization of the shock waves is performed by the ultrasound (US), to fully focus the shock waves on the stone
successful Shock wave lithotripsy , accurate localization of the shock waves is performed by ultrasound (US) to fully focus the shock waves on the stone
successful Shock wave lithotripsy , accurate localization of the shock waves is performed by fluoroscope (FS) to fully focus the shock waves on the stone

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lithotripsy or nephrolithotripsy by Shock waves
Time Frame: from baseline to 3 months after the Lithotripsy date.
Incidence of success of Nephrolithotripsy by using Fluoroscopic shock waves or Ultrasonic shock waves in pediatric renal pelvic stones.
from baseline to 3 months after the Lithotripsy date.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications of shockwave lithotripsy
Time Frame: through study completion, an average of 1 year

to evaluate postoperative complications of the lithotripsy as :

  1. Incidence of Hematuria
  2. Incidence of Fever
  3. Incidence of UTI
  4. Serum creatinine level in blood
  5. Rate of hydronephrosis
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Mahmoud Moubarak, Resident, Urology department - faculty of medicine, South Valley university.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2022

Primary Completion (Actual)

May 25, 2023

Study Completion (Actual)

May 30, 2023

Study Registration Dates

First Submitted

May 19, 2022

First Submitted That Met QC Criteria

June 9, 2022

First Posted (Actual)

June 10, 2022

Study Record Updates

Last Update Posted (Actual)

July 10, 2023

Last Update Submitted That Met QC Criteria

July 6, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stone, Kidney

Clinical Trials on ultrasonic focus Shock wave lithotripsy

Subscribe